Back
Verizon Communications Vs. Akero Therapeutics Industry Stock Comparison
Buy
62
VZ
Verizon Communications
Last Price:
$43.72
Seasonality Move:
1.14%
Buy
64
AKRO
Akero Therapeutics
Last Price:
$48.31
Seasonality Move:
19.25%
Buy
62
Verizon Communications (VZ)
is a Buy
Is Verizon Communications a Buy, Sell or Hold?
-
The current Verizon Communications [VZ] share price is $44.22. The Score for VZ is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
VZ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $47.57. The Score for AKRO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VZ Stock Price Chart
What is Verizon Communications's stock price today?
-
The Verizon Communications share price today is $44.22The current trend is moderately bullish and VZ is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $47.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
VZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 55.73 | Buy |
| Chaikin Money Flow: | -10708311 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.73 - 44.07) | Buy |
| Bollinger Bands (100): | (40.01 - 44.17) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 62.88 | Buy |
| Chaikin Money Flow: | 5010678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.26 - 43.96) | Buy |
| Bollinger Bands (100): | (31.45 - 49.59) | Buy |
VZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.45 | Buy |
| 20-day SMA: | 43.33 | Buy |
| 50-day SMA: | 43.63 | Buy |
| 200-day SMA: | 42.2 | Buy |
| 8-day EMA: | 43.71 | Buy |
| 20-day EMA: | 43.53 | Buy |
| 50-day EMA: | 43.28 | Buy |
| 200-day EMA: | 42.08 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.48 | Buy |
| 20-day SMA: | 41.93 | Buy |
| 50-day SMA: | 41.25 | Buy |
| 200-day SMA: | 34.59 | Buy |
| 8-day EMA: | 41.49 | Buy |
| 20-day EMA: | 41.25 | Buy |
| 50-day EMA: | 41.21 | Buy |
| 200-day EMA: | 36.22 | Buy |
Verizon Communications Earnings Growth & VZ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.09 per share, and an increase next year of $0.13 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.70 per share.
Verizon Communications Technical Analysis
| May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||